|
DIRECTORY
|
Product Information
Keywords: resveratrol, aging, cancer, Alzheimer’s, cardiovascular, atherosclerosis
About ilLuminol™
‘ilLuminol’ is LifeLink’s tradename for its resveratrol product, a nutritional supplement containing resveratrol and two bioavailability enhancers: quercetin and piperine. Resveratrol
itself is a substance found on grape skins and in certain other plants. It is produced by grapes in response to infection
by microorganisms. Chemically speaking, resveratrol is a ‘polyphenol’; functionally, it is an antioxidant and also has direct
effects on the activities of certain genes and proteins.
Intense research interest
Resveratrol was of little interest to researchers until the 1990s when it was discovered that it interferes with the clumping
of blood platelets. Since platelets are involved in the formation of the plaques that clog arteries and cause atherosclerosis,
it was suspected that resveratrol might turn out to be useful for preventing or treating cardiovascular disease. As more and
more researchers turned their attention to this promising agent, many other potential applications were revealed. By the beginning
of 2009 more than 2500 research studies had been published that dealt in some way with resveratrol.
What is it good for?
Resveratrol operates in the body at a fundamental level: it affects the activities of many genes. Consequently, its influence
can be seen in a wide variety of biological processes, including those that we associate with various diseases. The list of
possible medical applications is a long one, and includes the following areas:
- aging
- cancer
- arthritis
- Alzheimer’s
- heart disease, atherosclerosis, homocysteine excess
- platelet aggregation
- blood pressure
- stroke
- COPD, asthma
- liver damage, alcohol
- gastric ulcers
- leukemia
- diabetes
- fat, obesity
- retinal damage, glaucoma
- hearing damage
- neurodegeneration
- neuroprotection
- kidney damage
- male fertility
- multiple sclerosis
- vertebral disk degeneration
- sleep-wake cycle
- arsenic poisoning
Let’s look at two of these applications — aging and cancer — in a little more detail.
Does resveratrol slow, stop, or reverse aging?
It does for the experimental animals in which it has been tried: mice, rats, yeasts, worms , flies ,and fish. There is every reason to think that the same would be true for humans, but to prove it will require a clinical study lasting
approximately ten years. Would anyone volunteer for such a study if it were offered, knowing that they might receive a placebo
instead of resveratrol? “I certainly wouldn’t!” says LifeLink’s Dr. Zarkov, “when I can simply take a resveratrol supplement
and know that I’m getting the real thing.”
Aside from the animal studies, there is other indirect evidence that resveratrol has an anti-aging effect for humans. For
example, in a 2007 study of human skin cells it was found that resveratrol “inhibited expression of replicative senescence
marker INK4a” — that is, it altered the pattern of gene activity to produce a pattern like that found in skin cells of younger
individuals.
Does resveratrol prevent, slow, halt, or reverse cancer?
An abundance of research shows that it does. As stated by BB Aggarwal in 2004,
“Besides cardioprotective effects, resveratrol exhibits anticancer properties, as suggested by its ability to suppress proliferation
of a wide variety of tumor cells, including lymphoid and myeloid cancers; multiple myeloma; cancers of the breast, prostate,
stomach, colon, pancreas, and thyroid; melanoma; head and neck squamous cell carcinoma; ovarian carcinoma; and cervical carcinoma.”
It would be nice to be able to point to definitive clinical studies as proof of its anti-cancer effect in humans, but the
world of medicine does not understand the concept of ‘timely action’. Thus, no official human studies have been done — despite the fact that cancer is one of life’s biggest killers, and billions of dollars are spent each year on studying
and treating this disease. All of the relevant studies use lab animals and cell culture experiments. For example, a 2008 study
showed that resveratrol prevented liver cancer in rats. A 2002 study showed that it prevented and treated esophageal cancer in rats. In another rat study, it prevented colon cancer. Breast cancer suppression was shown in a cell culture study using human breast cancer cells. These and many other studies would convince any rational person that this is an anti-cancer supplement worth using — notwithstanding
the medical bureaucrats who claim that people should wait for years and years until huge clinical trials have been conducted
to prove that it works in humans.
How does it work?
The mechanisms through which resveratrol produces its effects against aging, cancer, and other ailments are not well understood.
It is known that resveratrol promotes the body’s production of two proteins, ‘sirtuin-1’ and ‘PCA-1α’ which are involved in
gene regulation, and it appears that the resulting pattern of gene activity affects the metabolism of fats and sugars, increases
the levels of certain antioxidants, and alters the production of a variety of proteins that are involved in the growth, proliferation,
and death of cells.
Bioavailability
The “bioavailability” of a substance is the fraction of a consumed substance that reaches the circulatory system unchanged
from the chemical form in which it was consumed. The term is sometimes used loosely to include altered forms that have the
desired activity in the body.
It is generally agreed that the bioavailability of orally consumed resveratrol itself is low — very little of it is absorbed
unaltered. But recent studies have shown that most of the consumed resveratrol is converted into absorbable derivatives which do end up in the blood. The still-unanswered question is: how much of these absorbable derivatives are converted back to resveratrol when they enter
the cells? If the percentage of back-conversion is low, then most of the consumed resveratrol is probably being wasted, since
the derivatives are not thought to be very biologically active, and are excreted quickly. In that case, it would be beneficial
to increase the absorption of resveratrol itself and block the formation of the derivatives. This is the approach that we
have taken at LifeLink — our resveratrol formulation, ilLuminol™, includes quercetin and piperine, which block the formation
of derivatives and enhance the absorption of the unaltered resveratrol.
Other polyphenols in grapes and other resveratrol sources
Plants that contain resveratrol always contain other interesting polyphenols, some of which contribute to the benefits of
resveratrol supplements. For example, the roots of Polygonum cuspidatum, the source of LifeLink’s resveratrol, also contain polydatin (a cholesterol regulator) and piceatannol (a substance with anti-cancer and anti-Alzheimer’s properties). Many of the polyphenols in these plants have yet to be studied in detail, and some of them are thought to have important
benefits. This is why LifeLink chose to include them in its formulation of Illuminol.
The problem of stability
Resveratrol does not ‘keep’ well compared to most supplements. It can be damaged by prolonged exposure to light, or by warm
temperatures in the presence of oxygen. Consequently, many of the resveratrol products on the market have lost most of their
potency by the time they reach the customer. To maintain the potency of resveratrol supplements these products should be protected
either from light and heat, or else from oxygen, from the time they are extracted from botanical sources until they reach
the customer; and then the customer should store them in a freezer — except for the jar that is currently in use, which should
be stored in a refrigerator. LifeLink’s resveratrol supplement is protected from bright light and is kept at temperatures
below 0°C (32°F) from the time of manufacture until it is shipped to the end-user.
Dosage
The optimum dosage of resveratrol probably depends upon the ailment one is trying to prevent or treat.
Epidemiological evidence suggests that the optimum dosage for preventing cardiovascular problems is just a few milligrams
per day — because it is thought that resveratrol in red wine is responsible for the low incidence of cardiovascular disease
in France, where fatty foods and red wine are both consumed in substantial amounts. A bottle of red wine contains typically
less than a milligram of resveratrol.
Anti-aging and anti-cancer effects may require much larger doses. No one knows how large. Single doses of up to 5000 mg of
resveratrol have been tested on volunteers and no significant negative side effects were seen. But few people could afford
the cost of such a regimen on a daily basis. Anti-cancer benefits in lab animals have been seen at doses ranging from 2 to
300 mg/kg body weight. This translates to about 24 to 3600 mg for a human (using the surface area method of scaling dosages). LifeLink has adopted
250 mg as a representative value for this range — an amount which is both affordable and plausible as an effective anti-cancer supplement.
Taking it on faith
Some supplements and drugs have benefits that are immediate and obvious — like aspirin, for example, which can provide pain
relief in less than an hour. Others, like resveratrol, have benefits that show up only with the passage of months, or even
years.
It’s difficult to maintain a regimen when the benefits can’t be seen right away. It’s difficult to continue spending money
on them, while wondering whether they are even working. This problem is made worse when one realizes that there are, in fact,
many substances on the market that don’t work. The cosmetics industry, for example, sells many phony, useless products, advertising them as “anti-aging” cremes and
the like.
Anyone who starts using resveratrol will soon realize that the beneficial effects it has on the body take place too slowly
to be noticed on a day-to-day, or even a month-to-month, basis. How, then, does one avoid ‘falling off the wagon’ — becoming
lax or forgetful about taking it daily, or deciding to save money by not reordering?
At LifeLink we are not inclined to use supplements “on faith” that they work, and we don’t expect our customers to do so,
either. That’s why this website contains so many technical references to support the products we have decided to sell. The
scientific research that is being directed at resveratrol gives us good reason to think that this substance is a true breakthrough
in the battle against aging and age-related diseases. Don’t just take our word for it: follow some of the links in the list of references below so that you’ll be able to use this supplement on the
basis of evidence, not faith.
And for additional support you can join the online resveratrol support group.
Is ilLuminol the ultimate anti-aging supplement?
In a word: no. This is just one step along the path to effective rejuvenation technology. A number of more powerful derivatives
of the resveratrol molecule are already being investigated as potential anti-aging substances, and eventually some of them will probably make it through the regulatory maze and reach the market — most likely as expensive
prescription drugs at first, until the developers have recovered the outrageously high development costs and then wrung as
much money out of the public as possible. Eventually they should be available as supplements — and by then, even more effective
rejuvenation technology should be under development.
It should also be mentioned that resveratrol and its derivatives affect just one of several causes of aging. Other substances
and methods will be required to deal with the other causes.
Good review articles on resveratrol
We highly recommend the review article in Wikipedia. Other good reviews are the ones by Guarente; the inflammatory diseases article by Shakibaei, et al; and the cancer articles by Athar and by Aziz.
|
|
|
|
For information on ingredients, click on the link(s)
in the table above to view images of the product label(s).
(Most images are approximately twice actual size and will open in a new window.)
|
|
|
References
[1] cancer apoptosis 2003 Resveratrol
[2] Modulation of sirtuins: new targets for antiageing. Recent Patents CNS Drug Discov. 2008 Jan; 3(1):61-9 Pallàs M, Verdaguer E, Tajes M, Gutierrez-Cuesta J, Camins A
[3] Sirtuins in aging and disease. Cold Spring Harb Symp Quant Biol. 2007; 72:483-8 Guarente L
[4] Nutrition, sirtuins and aging. Genes Nutr. 2006 Jun; 1(2):85-93 Wenzel U
[5] Quercetin mediated lifespan extension in Caenorhabditis elegans is modulated by age-1, daf-2, sek-1 and unc-43. Biogerontology. 2008 Nov 29; Pietsch K, Saul N, Menzel R, Stürzenbaum SR, Steinberg CE
[6] Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem Biophys Res Commun. 2008 Dec 8; Suchankova G, Nelson LE, Gerhart-Hines Z, Kelly M, Gauthier MS, Saha AK, Ido Y, Puigserver P, Ruderman NB
[7] Aging: An important factor for the pathogenesis of neurodegenerative diseases. Mech Ageing Dev. 2008 Nov 21; Farooqui T, Farooqui AA
[8] Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006 Nov 16; 444(7117):337-42 Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala
S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver
P, Ingram DK, de Cabo R, Sinclair DA
[9] Design and synthesis of compounds that extend yeast replicative lifespan. Aging Cell. 2007 Feb; 6(1):35-43 Yang H, Baur JA, Chen A, Miller C, Adams JK, Kisielewski A, Howitz KT, Zipkin RE, Sinclair DA
[10] Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life
span. Cell Metab. 2008 Aug; 8(2):157-68 Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang
Y, Dunn SR, Sharma K, Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Le Couteur D, Elliott PJ, Becker KG, Navas P, Ingram DK,
Wolf NS, Ungvari Z, Sinclair DA, de Cabo R
[11] Resveratrol addiction: To die or not to die. Mol Nutr Food Res. 2008 Dec 12; Shakibaei M, Harikumar KB, Aggarwal BB
[12] Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev. 2007 Jun; 16(6):1246-52 Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP,
Brenner DE
[13] The proteasome as a potential target for novel anticancer drugs and chemosensitizers. Drug Resist Updat. 2006 Dec; 9(6):263-73 Landis-Piwowar KR, Milacic V, Chen D, Yang H, Zhao Y, Chan TH, Yan B, Dou QP
[14] Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004 Sep-Oct; 24(5A):2783-840 Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y
[15] Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis. Eur J Cancer Prev. 2009 Feb; 18(1):13-25 Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR, Berry DP
[16] Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox
factor-1, which is inhibited by resveratrol. Mol Cancer Ther. 2008 Dec; 7(12):3751-60 Yang Z, Yang S, Misner BJ, Chiu R, Liu F, Meyskens FL
[17] Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: Inhibition of cell proliferation
and induction of apoptosis. Chem Biol Interact. 2008 Nov 27; Bishayee A, Dhir N
[18] Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma
cells. Int J Oncol. 2001 Jul; 19(1):83-8 De Lédinghen V, Monvoisin A, Neaud V, Krisa S, Payrastre B, Bedin C, Desmoulière A, Bioulac-Sage P, Rosenbaum J
[19] Wine and tumors: study of resveratrol. Drugs Exp Clin Res. 2003; 29(5-6):257-61 Bruno R, Ghisolfi L, Priulla M, Nicolin A, Bertelli A
[20] Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. Int J Oncol. 2006 Mar; 28(3):641-8 Lanzilli G, Fuggetta MP, Tricarico M, Cottarelli A, Serafino A, Falchetti R, Ravagnan G, Turriziani M, Adamo R, Franzese O,
Bonmassar E
[21] Resveratrol: a candidate nutritional substance for prostate cancer prevention. J Nutr. 2003 Jul; 133(7 Suppl):2440S-2443S Stewart JR, Artime MC, O'Brian CA
[22] New enlightenment of French Paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy. Cancer Biol Ther. 2007 Dec; 6(12):1833-6 Liu BL, Zhang X, Zhang W, Zhen HN
[23] Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int J Oncol. 2003 Jul; 23(1):17-28 Aziz MH, Kumar R, Ahmad N
[24] Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem Int. 2008 Nov 8; Karuppagounder SS, Pinto JT, Xu H, Chen LH, Beal MF, Gibson GE
[25] Therapeutic potential of resveratrol in Alzheimer's disease. BMC Neurosci. 2008; 9 Suppl 2:S6 Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P
[26] Acute responses to phytoestrogens in small arteries from men with coronary heart disease. Am J Physiol Heart Circ Physiol. 2006 May; 290(5):H1969-75 Cruz MN, Luksha L, Logman H, Poston L, Agewall S, Kublickiene K
[27] Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil. 2005 Dec; 12(6):596-600 Lekakis J, Rallidis LS, Andreadou I, Vamvakou G, Kazantzoglou G, Magiatis P, Skaltsounis AL, Kremastinos DT
[28] Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery. Int J Cardiol. 2005 Nov 2; 105(2):209-15 Rakici O, Kiziltepe U, Coskun B, Aslamaci S, Akar F
[29] Cardioprotective actions of grape polyphenols. Nutr Res. 2008 Nov; 28(11):729-37 Leifert WR, Abeywardena MY
[30] Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing
oxidative stress. J Nutr. 2005 Aug; 135(8):1911-7 Zern TL, Wood RJ, Greene C, West KL, Liu Y, Aggarwal D, Shachter NS, Fernandez ML
[31] Effect of resveratrol on platelet aggregation in vivo and in vitro. Chin Med J (Engl). 2002 Mar; 115(3):378-80 Wang Z, Zou J, Huang Y, Cao K, Xu Y, Wu JM
[32] Beneficial effects of resveratrol on atherosclerosis. J Med Food. 2008 Dec; 11(4):610-4 Fan E, Zhang L, Jiang S, Bai Y
[33] Resveratrol supplementation worsen the dysregulation of genes involved in hepatic lipid homeostasis observed in hyperhomocysteinemic
mice. Food Chem Toxicol. 2008 Nov 7; Noll C, Hamelet J, Ducros V, Belin N, Paul JL, Delabar JM, Janel N
[34] Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol. 2008 Dec 3; Rivera L, Morón R, Zarzuelo A, Galisteo M
[35] Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral
ischemia. Brain Res. 2008 Nov 11; Yousuf S, Atif F, Ahmad M, Hoda N, Ishrat T, Khan B, Islam F
[36] Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax. 2003 Nov; 58(11):942-6 Culpitt SV, Rogers DF, Fenwick PS, Shah P, De Matos C, Russell RE, Barnes PJ, Donnelly LE
[37] trans-resveratrol alone and hydroxystilbenes of rhubarb (Rheum rhaponticum L.) root reduce liver damage induced by chronic
ethanol administration: a comparative study in mice. Phytother Res. 2008 Dec 9; Raal A, Pokk P, Arend A, Aunapuu M, Jõgi J, Okva K, Püssa T
[38] Improved anti-ulcer and anticancer properties of a trans-resveratrol analog in mice. J Pharmacol Exp Ther. 2008 Dec 9; Guha P, Dey A, Sarkar B, Dhyani MV, Chattopadhyay S, Bandyopadhyay SK
[39] Antileukemic mechanism of resveratrol in vitro and in mice bearing L1210-tumor. Zhong Xi Yi Jie He Xue Bao. 2008 Dec; 6(12):1267-74 Li T, Wang W, Li T
[40] Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced
diabetic rats. Chem Biol Interact. 2008 Nov 19; Palsamy P, Subramanian S
[41] Overexpression of SIRT1 protects pancreatic {beta}-cells against cytokine toxicity through suppressing NF-{kappa}B signaling
pathway. Diabetes. 2008 Nov 13; Lee JH, Song MY, Song EK, Kim EK, Sung Moon W, Han MK, Park JW, Kwon KB, Park BH
[42] Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes. J Med Food. 2008 Dec; 11(4):773-83 Park HJ, Yang JY, Ambati S, Della-Fera MA, Hausman DB, Rayalam S, Baile CA
[43] Resveratrol and large-conductance calcium-activated potassium channels in the protection of human retinal pigment epithelial
cells. J Ocul Pharmacol Ther. 2008 Dec; 24(6):551-5 Sheu SJ, Bee YS, Chen CH
[44] Resveratrol prevents antibody-induced apoptotic death of retinal cells through upregulation of Sirt1 and Ku70. BMC Res Notes. 2008 Dec 1; 1(1):122 Anekonda TS, Adamus G
[45] Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells. Food Chem Toxicol. 2008 Nov 6; Luna C, Li G, Liton PB, Qiu J, Epstein DL, Challa P, Gonzalez P
[46] Resveratrol protects auditory hair cells from gentamicin toxicity. Ear Nose Throat J. 2008 Oct; 87(10):570-3 Bonabi S, Caelers A, Monge A, Huber A, Bodmer D
[47] SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 2007 Jul 11; 26(13):3169-79 Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, Puigserver P, Sinclair
DA, Tsai LH
[48] Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS ONE. 2008; 3(12):e4090 Pfister JA, Ma C, Morrison BE, D'Mello SR
[49] Protective effect of resveratrol on acute endotoxemia-induced nephrotoxicity in rat through nitric oxide independent mechanism. Free Radic Res. 2008 Nov; 42(11):913-20 Sebai H, Ben-Attia M, Sani M, Aouani E, Ghanem-Boughanmi N
[50] Resveratrol reestablishes spermatogenesis after testicular injury in rats caused by 2, 5-hexanedione. Chin Med J (Engl). 2008 Jul 5; 121(13):1204-9 Jiang YG, Peng T, Luo Y, Li MC, Lin YH
[51] Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased
IL-17(+)IL-10(+) T cells, CD4(-) IFN-gamma(+) cells, and decreased macrophage IL-6 expression. Int Immunopharmacol. 2008 Nov 17; Imler TJ, Petro TM
[52] The action of resveratrol, a phytoestrogen found in grapes, on the intervertebral disc. Spine. 2008 Nov 15; 33(24):2586-95 Li X, Phillips FM, An HS, Ellman M, Thonar EJ, Wu W, Park D, Im HJ
[53] Resveratrol regulates circadian clock genes in rat-1 fibroblast cells. Biosci Biotechnol Biochem. 2008 Nov; 72(11):3038-40 Oike H, Kobori M
[54] Protective effect of dietary phytochemicals against arsenite induced genotoxicity in mammalian V79 cells. Indian J Exp Biol. 2008 Oct; 46(10):690-7 Roy M, Sinha D, Mukherjee S, Paul S, Bhattacharya RK
[55] A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS ONE. 2008; 3(6):e2264 Barger JL, Kayo T, Vann JM, Arias EB, Wang J, Hacker TA, Wang Y, Raederstorff D, Morrow JD, Leeuwenburgh C, Allison DB, Saupe
KW, Cartee GD, Weindruch R, Prolla TA
[56] Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging. J Agric Food Chem. 2008 Nov 26; 56(22):10544-51 Joseph JA, Fisher DR, Cheng V, Rimando AM, Shukitt-Hale B
[57] Trans-resveratrol: a magical elixir of eternal youth? Curr Med Chem. 2008; 15(19):1887-98 Orallo F
[58] Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004 Aug 5; 430(7000):686-9 Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D
[59] Resveratrol and the pharmacology of aging: a new vertebrate model to validate an old molecule. Cell Cycle. 2006 May; 5(10):1027-32 Valenzano DR, Cellerino A
[60] The effect of resveratrol on a cell model of human aging. Ann N Y Acad Sci. 2007 Oct; 1114:407-18 Stefani M, Markus MA, Lin RC, Pinese M, Dawes IW, Morris BJ
[61] Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis. 2002 Sep; 23(9):1531-6 Li ZG, Hong T, Shimada Y, Komoto I, Kawabe A, Ding Y, Kaganoi J, Hashimoto Y, Imamura M
[62] Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis. 2000 Aug; 21(8):1619-22 Tessitore L, Davit A, Sarotto I, Caderni G
[63] Mechanism of human SIRT1 activation by resveratrol. J Biol Chem. 2005 Apr 29; 280(17):17187-95 Borra MT, Smith BC, Denu JM
[64] Resveratrol transport and metabolism by human intestinal Caco-2 cells. J Pharm Pharmacol. 2003 Mar; 55(3):307-12 Kaldas MI, Walle UK, Walle T
[65] Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006 Jun; 5(6):493-506 Baur JA, Sinclair DA
[66] Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res. 2005 May; 49(5):472-81 Wenzel E, Somoza V
[67] Intestinal BCRP/Bcrp1 and MRP3/Mrp3 are involved in the pharmacokinetics of resveratrol. Mol Pharmacol. 2008 Dec 29; van de Wetering K, Burkon A, Feddema W, Bot A, de Jonge H, Somoza V, Borst P
[68] Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal. 1997; 11(5):287-313 Soleas GJ, Diamandis EP, Goldberg DM
[69] [Contents comparison of resveratrol and polydatin in the wild Polygonum cuspidatum plant and its tissue cultures] Zhongguo Zhong Yao Za Zhi. 2006 Apr; 31(8):637-41 Yu SH, Zha JP, Zhan WH, Zhang DQ
[70] Protective effects of piceatannol against beta-amyloid-induced neuronal cell death. Ann N Y Acad Sci. 2007 Jan; 1095:473-82 Kim HJ, Lee KW, Lee HJ
[71] The geometric mean value of this range, (24*3600)^(1/2) = 294, serves as the basis for LifeLink’s resveratrol dosage of 250
mg/capsule.
[72] Pharmacometrics of stilbenes: seguing towards the clinic. Curr Clin Pharmacol. 2006 Jan; 1(1):81-101 Roupe KA, Remsberg CM, Yáñez JA, Davies NM
[73] Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol. 2007 Nov 1; 224(3):274-83 Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL
Pronunciation: resveratrol 
— RM
Last modified 2009.May.18
|
|